CADEMA  CDMA PLANS PREFERRED OFFERING MIDDLETOWN NY MARCH 4 CADEMA CORP SAID IT ENTERED A LETTER OF INTENT WITH A NATIONAL UNDERWRITING FIRM FOR AN OFFERING OF FIVE MLN DLRS WORTH OF CONVERTIBLE PREFERRED STOCK CADEMA SAID IT WILL FILE A REGISTRATION STATEMENT WITH THE SECURITIES AND EXCHANGE COMMISSION LATER THIS MONTH FOR THE OFFERING PROCEEDS WILL BE USED TO FUND CLINICAL TRIALS FOR THE COMPANY'S TREATMENTS FOR RHEUMATOID ARTHRITIS AND METASTATIC BONE CANCER IT ALSO SAID IT INCREASED THE SIZE OF ITS BOARD TO SIX FROM FIVE MEMBERS   